Universal eryhrodermia, KELA reimbursement

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

KELA reimbursements: KELA codes 134

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector L12_ERYTHRO_KELA

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 215 80 135
Unadjusted prevalence (%) 0.08 0.05 0.12
Mean age at first event (years) 48.64 45.69 50.39

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.01 0.88 [0.29, 2.66] 8.2e-1 22
15 years 0.01 0.97 [0.35, 2.73] 9.6e-1 13
5 years - - - -
1 year - - - -

Correlations

Index endpoint: L12_ERYTHRO_KELA – Universal eryhrodermia, KELA reimbursement
GWS hits: 2

Survival analyses between endpoints

Plot

before Universal eryhrodermia, KELA reimbursement
after Universal eryhrodermia, KELA reimbursement

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Universal eryhrodermia, KELA reimbursement